|
RECQL expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.839900E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.301400E-03 |
| Normal-vs-Stage2 |
2.199300E-04 |
| Normal-vs-Stage3 |
1.077740E-02 |
| Normal-vs-Stage4 |
1.733700E-02 |
| Stage1-vs-Stage2 |
5.725500E-02 |
| Stage1-vs-Stage3 |
8.336200E-01 |
| Stage1-vs-Stage4 |
7.391200E-01 |
| Stage2-vs-Stage3 |
1.451830E-01 |
| Stage2-vs-Stage4 |
2.129200E-01 |
| Stage3-vs-Stage4 |
8.882400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.182900E-03 |
| Normal-vs-AfricanAmerican |
1.517150E-01 |
| Normal-vs-Asian |
1.426630E-01 |
| Caucasian-vs-AfricanAmerican |
7.418200E-01 |
| Caucasian-vs-Asian |
5.788400E-01 |
| AfricanAmerican-vs-Asian |
9.388600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.204000E-04 |
| Normal-vs-Female |
2.018900E-03 |
| Male-vs-Female |
3.325200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.677800E-02 |
| Normal-vs-Age(41-60Yrs) |
4.391500E-04 |
| Normal-vs-Age(61-80Yrs) |
9.369600E-04 |
| Normal-vs-Age(81-100Yrs) |
2.640800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.399640E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.071830E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.405600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.309800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.849800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.058200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.819200E-01 |
| Classical-VS-Follicular |
1.19290000100136E-09 |
| Classical-VS-Other |
8.810200E-02 |
| Classical-VS-Normal |
1.233000E-01 |
| Tall-VS-Follicular |
5.60219999999889E-05 |
| Tall-VS-Other |
1.042830E-01 |
| Tall-VS-Normal |
6.946200E-01 |
| Follicular-VS-Other |
7.715400E-01 |
| Follicular-VS-Normal |
3.50090001433045E-09 |
| Other-VS-Normal |
1.181930E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.26489999999302E-06 |
| Normal-vs-N1 |
1.778020E-02 |
| N0-vs-N1 |
2.501200E-01 |
|
|
